Interestingly, only high PRKD1 expression was associated with a lower metastasis-free survival independently of the BC subtype (p=0.0083; Figure 1C), whereas PRKD2 or PRKD3 expressions did not significantly correlate with prognosis (Supplementary Figure 2). Here, PRKD1 is linked to breast cancer.